BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 24507046)

  • 1. Development of urologic de novo malignancies after renal transplantation.
    Hevia V; Gómez V; Díez Nicolás V; Alvarez S; Gómez Del Cañizo C; Galeano C; Gomis A; García-Sagredo JM; Marcen R; Burgos FJ
    Transplant Proc; 2014; 46(1):170-5. PubMed ID: 24507046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Urologic malignancies in renal transplant candidates and recipients].
    Kleinclauss F; Thuret R; Murez T; Timsit MO
    Prog Urol; 2016 Nov; 26(15):1094-1113. PubMed ID: 27665407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transitional cell carcinoma in renal transplant recipients: a single center experience.
    Li XB; Xing NZ; Wang Y; Hu XP; Yin H; Zhang XD
    Int J Urol; 2008 Jan; 15(1):53-7. PubMed ID: 18184173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [De novo urological neoplasms in kidney transplant patients: experience in 1,751 patients].
    di Capua Sacoto C; Luján Marco S; Bahilo Mateu P; Budía Alba A; Pontones Moreno JL; Jiménez Cruz JF
    Actas Urol Esp; 2010 Jan; 34(1):88-94. PubMed ID: 20223138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of microscopic hematuria in the evaluation of urologic malignancy in renal transplant recipients.
    Kim DY; Abouljoud M; Parasuraman R
    Transplant Proc; 2010 Jun; 42(5):1641-2. PubMed ID: 20620491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo renal cell carcinoma of native kidney in renal transplant recipients.
    Neuzillet Y; Lay F; Luccioni A; Daniel L; Berland Y; Coulange C; Lechevallier E
    Cancer; 2005 Jan; 103(2):251-7. PubMed ID: 15593084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urological malignancy as a complication of renal transplantation: a report of twelve clinical cases.
    Zhou M; Zhu Y; Wang L; Wang Y; Fu S; Min Z
    Clin Transpl; 2006; ():395-8. PubMed ID: 18365395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [De novo urologic tumors in kidney transplant patients].
    Rodríguez Faba O; Breda A; Gausa L; Palou J; Villavicencio H
    Actas Urol Esp; 2015 Mar; 39(2):122-7. PubMed ID: 24996779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genitourinary tumor following kidney transplantation: a multicenter study.
    Einollahi B; Simforoosh N; Lessan-Pezeshki M; Basiri A; Nafar M; Pour-Reza Gholi F; Firouzan A; Ahmadpour P; Makhdomi K; Ghafari A; Taghizadeh A; Tayebi Khosroshahi H
    Transplant Proc; 2009 Sep; 41(7):2848-9. PubMed ID: 19765454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic management of de novo urological malignancy in renal transplant recipients: the experience of the French Department of Urology and Kidney Transplantation from Bordeaux.
    Elkentaoui H; Robert G; Pasticier G; Bernhard JC; Couzi L; Merville P; Ravaud A; Ballanger P; Ferrière JM; Wallerand H
    Urology; 2010 Jan; 75(1):126-32. PubMed ID: 19864001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urologic de novo malignancies after kidney transplantation: a single center experience.
    Karczewski M; Czapiewski W; Karczewski J
    Transplant Proc; 2012 Jun; 44(5):1293-7. PubMed ID: 22664003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo urothelial carcinoma in kidney transplant patients with end-stage aristolochic acid nephropathy in China.
    Yuan M; Shi YB; Li ZH; Xia M; Ji GZ; Xu GX; Han Y
    Transplant Proc; 2009 Jun; 41(5):1619-23. PubMed ID: 19545692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transitional cell carcinoma in renal transplant recipients.
    Liao CH; Chueh SC; Lai MK; Chen J
    Transplant Proc; 2004 Sep; 36(7):2152-3. PubMed ID: 15518781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of renal masses in transplant allografts at an Australian kidney-pancreas transplant unit.
    Su MZ; Campbell NA; Lau HM
    Transplantation; 2014 Mar; 97(6):654-9. PubMed ID: 24212503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urological tumors in renal transplantation.
    Tillou X; Doerfler A
    Minerva Urol Nefrol; 2014 Mar; 66(1):57-67. PubMed ID: 24721941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Native nephrectomy for renal cell carcinoma in transplant recipients.
    Suson KD; Sausville JE; Sener A; Phelan MW
    Transplantation; 2011 Jun; 91(12):1376-9. PubMed ID: 21512434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De Novo Urologic Malignancies in Renal Transplant Recipients.
    Antunes H; Tavares-da-Silva E; Oliveira R; Carvalho J; Parada B; Bastos C; Figueiredo A
    Transplant Proc; 2018 Jun; 50(5):1348-1354. PubMed ID: 29753463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo malignancies in renal transplant recipients: experience at a single center with 1882 transplant patients over 39 yr.
    Apel H; Walschburger-Zorn K; Häberle L; Wach S; Engehausen DG; Wullich B
    Clin Transplant; 2013; 27(1):E30-6. PubMed ID: 23278453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical character of renal transplant recipients with bilateral native upper urinary transitional cell carcinoma].
    Zhang P; Wang Y; Zhang XD; Hu XP; Wang W; Zhang Y; Yin H
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):248-50. PubMed ID: 19552841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The management of transitional cell carcinoma (TCC) in a European regional renal transplant population.
    Rogers A; Ng JK; Glendinning J; Rix D
    BJU Int; 2012 Jul; 110(2 Pt 2):E34-40. PubMed ID: 22243691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.